Warp: I thought the "Pilot Study" was completed a few
Warp: I thought the "Pilot Study" was completed a few months ago. Today's PR referred to a "bridge study" they were just now conducting and which he says was formerly referred to as the "Pilot Study." This "Bridge Study" is comparing version 1 with version 2 of LymPro. He says they hope to reveal the "top line results" of this study in two weeks. Have you ever heard of this until today? You weren't surprised by this today? It sounds new to me.
Copenhagen was to be the showcase of our impressive LymPro data to the AD community. But truthfully, as closely as I've followed LymPro, and even though I have a College Degree, all the different changing test names it has been going through is all mush to me.
I can't positively tell you what tests we presented in the posters and which tests we'll present in two weeks. It is anything but straight forward! I'm not an idiot, I am capable of understanding things. But I really can't explain very well what Amarantus has been doing with LymPro over the past year! It should be easy to list each test, it's name, it's results, and there, you have it. But they haven't made it that straight forward.
Warp: Can you lay out the 3 or 4 or 5 tests they've done on LymPro for me? I'd love to know the name of each test, how many patients were studied, and what the results were of each test. I'm not really sure what we presented yesterday. Was it the pilot study we did in the first quarter this year, or was it a part of the validation BD did last year? I know we presented the 7 year study today. It's unclear.
And this new "Bridge Study" is totally new. Instead of getting LymPro's big results in Copenhagen, we were told of a new test that won't even be completed by the Summit. I think we all would like more transparency and clarity about an issue so important to us.
Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
California's Election Integrity: A Ticking Time Bomb Strap in for a bumpy ride, folks—California might soon find its electoral process caught in a Washington whirlwind. CalExitNow, the group advocating for California's independence, is sounding alarms about looming federal interventions that could shake the state's democratic foundations. The Federal Storm Rolling In...
Continue Reading
Rewriting the Playbook in Global Skincare AXIS-Y decided to do things their way, not just because they could afford to, but because they believed in their vision. Their strategy defies the trends-driven tactics of this cutthroat beauty world. Instead, they’ve been all about climate-inspired products and vegan, cruelty-free standards. And now, after notching up some...
Continue Reading
An Intriguing Move For Baidu's Class A Shares Well, here we go again, folks. Another move on the chessboard for Baidu. They've just walked their Class A ordinary shares onto the Shenzhen-Hong Kong and Shanghai-Hong Kong Stock Connects. As of today, September 7, 2026, mainland investors can now get their mitts on these shares more easily. It might not be a...
Continue Reading
Under the shadows of Manhattan's skyline, something more than a regular service took shape. The New Yorker Hotel hosted an impassioned gathering of the Family Federation for World Peace and Unification. These folks weren't just saying their prayers; they were making a call—loud and resonant—for the release of Dr. Hak Ja Han. The Power of Collective Voices Gathering in...
Continue Reading
Unprecedented Scale at CIMAMotor 2026 Come September, the 24th China International Motorcycle Trade Exhibition, also known as CIMAMotor 2026, is set to roar through the corridors of the Chongqing International Expo Center. With more than 1,000 exhibitors and over 3,000 vehicles on display, it’s clear this isn’t just another trade show—this is a full-blown spectacle...
Continue Reading
Decoding the RNA Revolution Ever heard of circular RNA (circRNA)? This ain't your typical strand of genetic code. Unlike their straight-laced, linear counterparts, these RNAs form a loop you can't just break. Picture them as the Kevlar vests of the RNA world—tough, resilient, and packing the promise of next-gen treatments in their covalent loops. Here we’ve got...
Continue Reading
An Unprecedented Performance: A Halftime Show for the Ages Hold onto your hats, folks—Bad Bunny and his Super Bowl LX Halftime Show have taken home a jaw-dropping seven Emmys at the 78th Emmy Awards. This is uncharted territory for any Super Bowl Halftime Show. Never before has a halftime spectacle swept the Emmys like this. We’re talking about categories such as...
Continue Reading
The Big Leap: Harbour BioMed Joins Stock Connect Well, if this ain't something to get excited about—Harbour BioMed just snagged a spot on the Stock Connect roster. This step isn't just ceremonial. We're talking about real access for mainland Chinese investors to dive directly into the shares of Harbour BioMed (HKEX: 02142.HK) through the Shanghai-Hong Kong and...
Continue Reading
Trophy Time for Zendure in Berlin The Berlin Chronicles of 2026 tell an interesting tale for Zendure—a tale where top honors and glowing recognition highlight its efforts in the sustainable energy arena. At the Global Product Technology Innovation Awards, Zendure's SolarFlow 4000 Mix Pro snagged the Gold for Sustainable Home Energy Storage System. Not only that, but...
Continue Reading
UST's Strategic Move Into Automotive's Future Wake up and smell the coffee, because UST is shaking up the automotive scene. They've just pulled off a major play by grabbing a majority stake in Italdesign. If that doesn't scream the next leap forward for the auto world, I don't know what does. UST isn't just buying a company; it's marrying Italdesign's legendary design...
Continue Reading
Top 5 Most Recently Viewed Articles
New Final Bond Terms Released for Nykredit Realkredit A/S Nykredit Realkredit A/S has announced the issuance of new Final Bond Terms as part of its ongoing commitment to provide transparency and clarity to investors. This follows the introduction of new ISINs under the company’s Base Prospectus. Overview of the Bond Series The latest bonds, designated as series 13H,...
Continue Reading
CECO Environmental: Anticipating Earnings and Future Growth CECO Environmental (NASDAQ: CECO) is gearing up to share its quarterly earnings soon. Investors are eager for updates and insights about the company's performance. Understanding what to expect in the upcoming announcement is vital for both new and existing shareholders. Analysts predict that CECO Environmental...
Continue Reading
Overview of the Polyglycolic Acid Market The global polyglycolic acid (PGA) market is witnessing remarkable growth, with projections suggesting an expansion from USD 5.72 billion in recent years to an impressive USD 12.01 billion by 2032. This translates to a compound annual growth rate (CAGR) of 9.72% from 2025 onwards, a clear indication of the rising demand across...
Continue Reading
Brera Holdings Aims to Acquire Serie B Football Club Brera Holdings PLC (Nasdaq: BREA), headquartered in Dublin and Milan, has made an exciting move in the football scene by announcing an exclusive letter of intent to acquire an Italian Serie B football club. This strategic step showcases Brera's ambition to transform professional sports investment on a global scale. As...
Continue Reading
Zip's Groundbreaking Year in Procurement Orchestration In 2024, Zip has made significant strides in the world of procurement orchestration, positioning itself as an indispensable platform for global enterprises. By processing over $107 billion in spend and collaborating with industry giants like Hewlett-Packard (HP), Advanced Micro Devices (AMD), and Anthropic, Zip...
Continue Reading